These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10072906)
1. Several new targets of antitumor agents. Wang XW; Xu B Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):289-92. PubMed ID: 10072906 [TBL] [Abstract][Full Text] [Related]
2. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Kawai HF; Kaneko S; Honda M; Shirota Y; Kobayashi K Hepatology; 2001 Mar; 33(3):676-91. PubMed ID: 11230749 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate. Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311 [TBL] [Abstract][Full Text] [Related]
4. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Tang H; Tang XY; Liu M; Li X Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897 [TBL] [Abstract][Full Text] [Related]
5. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409 [TBL] [Abstract][Full Text] [Related]
6. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha. Hung WC; Chuang LY Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647 [TBL] [Abstract][Full Text] [Related]
9. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells]. Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481 [TBL] [Abstract][Full Text] [Related]
11. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma]. Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267 [TBL] [Abstract][Full Text] [Related]
12. Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation. Kang JH; Shi YM; Zheng RL Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1019-24. PubMed ID: 11270968 [TBL] [Abstract][Full Text] [Related]
13. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. Ma XJ; Huang R; Kuang AR Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells. Sasaki K; Kawasaki S; Okita K; Murakami T; Takemoto T; Takahashi M Jpn J Cancer Res; 1986 Mar; 77(3):264-9. PubMed ID: 2422145 [TBL] [Abstract][Full Text] [Related]
15. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
16. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802 [TBL] [Abstract][Full Text] [Related]
20. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]